Tech Company Financing Transactions

Terrestrial Bio Funding Round

Terrestrial Bio, operating out of Woburn, secured $3.6 million in funding from private investors.

Transaction Overview

Company Name
Announced On
2/16/2019
Transaction Type
Venture Equity
Amount
$3,575,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 4 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
30 Cummings Park Dr.
Woburn, MA 01801
USA
Phone
Undisclosed
Email Address
Overview
Terrestrial imagines a needle-free, refrigeration-free future of administering therapeutics -- from the comfort of your home, or anywhere you go. Our Mission: Mapping a future where anyone can benefit from next-gen therapies in a convenient, patient-friendly way. We are a group of life scientists, engineers, and entrepreneurs challenging ourselves and others to create breakthrough biomedical innovation, and make it available to people everywhere.
Profile
Terrestrial Bio LinkedIn Company Profile
Social Media
Terrestrial Bio Company Twitter Account
Company News
Terrestrial Bio News
Facebook
Terrestrial Bio on Facebook
YouTube
Terrestrial Bio on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Rachel Sha
  Rachel Sha LinkedIn Profile  Rachel Sha Twitter Account  Rachel Sha News  Rachel Sha on Facebook
Chief Scientific Officer
Kathryn Kosuda
  Kathryn Kosuda LinkedIn Profile  Kathryn Kosuda Twitter Account  Kathryn Kosuda News  Kathryn Kosuda on Facebook
VP - Bus. Development
Lynda Tussey
  Lynda Tussey LinkedIn Profile  Lynda Tussey Twitter Account  Lynda Tussey News  Lynda Tussey on Facebook
VP - Engineering
Matthew Dirckx
  Matthew Dirckx LinkedIn Profile  Matthew Dirckx Twitter Account  Matthew Dirckx News  Matthew Dirckx on Facebook
VP - Manufacturing
Ray Knox
  Ray Knox LinkedIn Profile  Ray Knox Twitter Account  Ray Knox News  Ray Knox on Facebook
VP - Operations
Livio Valenti
  Livio Valenti LinkedIn Profile  Livio Valenti Twitter Account  Livio Valenti News  Livio Valenti on Facebook
VP - Product Management
John Spiridigliozzi
  John Spiridigliozzi LinkedIn Profile  John Spiridigliozzi Twitter Account  John Spiridigliozzi News  John Spiridigliozzi on Facebook
VP - R & D
Jonathan Kluge
  Jonathan Kluge LinkedIn Profile  Jonathan Kluge Twitter Account  Jonathan Kluge News  Jonathan Kluge on Facebook
VP - Regulatory Affairs
Weiner Tilsner
  Weiner Tilsner LinkedIn Profile  Weiner Tilsner Twitter Account  Weiner Tilsner News  Weiner Tilsner on Facebook


 

 

Browse more venture capital transactions:

Prev: 2/16/2019: Remine venture capital transaction
Next: 2/16/2019: Castle Biosciences venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. VC transactions reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary